We are very sorry but it looks like you are using an outdated browser. We strongly recommend updating to a modern browser.
More information about your browser and how to update

Baxter Innovations GmbH

Baxter is a global healthcare company that assists healthcare professionals and patients with treatment of complex medical conditions.

Baxter’s BioScience business is a leader in recombinant and plasma-based protein replacement therapies to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technology used in adult stem-cell therapies; and vaccines.

BioScience core business units include: Hemophilia, Biotherapeutics, Regenerative Medicine and Vaccines. BioScience products represent approximately 44 percent of Baxter’s annual sales, totaling $5.3 billion in 2008.


Baxter Innovations GmbH

Industriestraße 67
1221 Wien
Field of Activity:
Research & Education
Number of employess:
more than 500